Lenvatinib shows promise
- PMID: 26526757
- DOI: 10.1038/nrurol.2015.262
Lenvatinib shows promise
Comment on
-
Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial.Lancet Oncol. 2015 Nov;16(15):1473-1482. doi: 10.1016/S1470-2045(15)00290-9. Epub 2015 Oct 22. Lancet Oncol. 2015. PMID: 26482279 Clinical Trial.
References
-
- Lancet Oncol. 2015 Nov;16(15):1473-82 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
